相关产品推荐更多 >

EZElisa™易位相关缺口同源物1(TAN1)试剂盒-EZElisa™ Translocation Associated Notch Homolog 1 (TAN1) Kit
询价
EZElisa™ Supervillin(SVIL)ELISA试剂盒-EZElisa™ Supervillin (SVIL) ELISA Kit
询价
EZElisa™ Thiet Oligopeptidase 1(THOP 1)ELISA试剂盒-EZElisa™ Thimet Oligopeptidase 1 (THOP1) ELISA Kit
询价
EZElisa™人补体片段5b(C5b)ELISA试剂盒-EZElisa™ Human Complement Fragment 5b (C5b) ELISA Kit
询价
EZElisa™人骨形态发生蛋白3(BMP 3)ELISA试剂盒-EZElisa™ Human Bone Morphogenetic Protein 3 (BMP3) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
运输过程中保存:2-8℃
- 保质期:
1年
- 英文名:
EZElisa™ Rat Transforming Growth Factor Beta Receptor I (TGFbR1) ELISA Kit
- 库存:
100
- 供应商:
艾美捷科技
EZElisa™大鼠转化生长因子β受体I(TGFbR1)ELISA试剂盒,EZElisa™ Rat Transforming Growth Factor Beta Receptor I (TGFbR1) ELISA Kit,转化生长因子β受体I(TGFbR1)ELISA试剂盒, Rat Transforming Growth Factor Beta Receptor I (TGFbR1) ELISA Kit
产品名称:EZElisa™大鼠转化生长因子β 2(TGF β 2)ELISA试剂盒-EZElisa™ Rat Transforming Growth Factor Beta Receptor I (TGFbR1) ELISA Kit
产品货号:A-QEK12022-96wells
产品规格:96wells

Enzyme Immunoassay for the estimation of Rat Transforming Growth Factor Beta Receptor I (TGFbR1) in serum and plasma, tissue homogenates and other biological fluids.
种属:Rat
检测方法:比色法
检测范围:0.312-20ng/mL

该EZElisa™大鼠转化生长因子β受体I(TGFbR1)ELISA试剂盒ELISA的特点包括:即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证,符合金环标准质量ELISA的要求,这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物,样品可以是血清

运输过程中保存:2-8℃
点击:EZElisa™大鼠转化生长因子β 2(TGF β 2)ELISA试剂盒-EZElisa™ Rat Transforming Growth Factor Beta Receptor I (TGFbR1) ELISA Kit更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Transforming Growth Factor-: A Key Mediator of Fibrosis
Transforming growth factor (TGF)-β is a prototypic multifunctional cytokine whose broad modulatory mechanisms affect numerous biological functions both at the cell and organism levels. These include, but are not limited to, control of immune
Transforming Growth Factor Beta: A Plasma Tumor Marker
Malignant tumors have been known for many years to release proteins or polypeptides into the circulation (for review, see ref. 1 ). Some of these molecules have biological activity, resulting in endocrinologic manifestations of malignancy
Dynamic Monitoring of Cellular Remodeling Induced by the Transforming Growth Factor-1
epithelial cells with the transforming growth factor-β1. Changes in the cell index profile were paralleled with cytoskeleton rebuilding and induction of epithelial–mesenchymal transition and negatively correlated with cell proliferation. This novel
技术资料暂无技术资料 索取技术资料




